Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

Ying, Haoqiang, Kimmelman, Alec C., Lyssiotis, Costas A., Hua, Sujun, Chu, Gerald C., Fletcher-Sananikone, Eliot, Locasale, Jason W., Son, Jaekyoung +23 more·2012·Cell

DOI 10.1016/j.cell.2012.01.058

Cited by (1,006)

Items 501–600 of 1,006

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia
Javier García‐Bermúdez, Michael A. Badgley, Sheela Prasad, Lou Baudrier, Yuyang Liu, Konnor La, Mariluz Soula, Robert T. Williams, Norihiro Yamaguchi, Rosa F. Hwang et al. · 2022 · Nature Metabolism
Metabolic pathway analysis using stable isotopes in patients with cancer
Caroline Bartman, Brandon Faubert, Joshua D. Rabinowitz, Ralph J. DeBerardinis · 2023 · Nature reviews. Cancer
Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer
Wan-Chi Lin, Nirakar Rajbhandari, Chengbao Liu, Kazuhito Sakamoto, Qian Zhang, Aleata A. Triplett, Surinder K. Batra, René Opavský, Dean W. Felsher, Dominick J. DiMaio et al. · 2013 · Cancer Research
Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
Piergiorgio Pettazzoni, Andrea Viale, Parantu K. Shah, Alessandro Carugo, Haoqiang Ying, Huamin Wang, Giannicola Genovese, Sahil Seth, Rosalba Minelli, Tessa Green et al. · 2015 · Cancer Research
Coordinated transcriptional and catabolic programs support iron-dependent adaptation to RAS-MAPK pathway inhibition in pancreatic cancer
Ravichandran, Mirunalini, Hu, Jingjie, Cai, Charles, Ward, Nathan P., Venida, Anthony, Foakes, Callum, Kuljanin, Miljan, Yang, Annan, Hennessey, Connor J., Yang, Yang et al. · 2022 · Cancer Discovery
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Halbrook, Christopher J., Thurston, Galloway, Boyer, Seth, Anaraki, Cecily, Jiménez, Jennifer A., McCarthy, Amy, Steele, Nina G., Kerk, Samuel A., Hong, Hanna S., Lin, Lin et al. · 2022 · Nature Cancer
Metabolic traits of cancer stem cells
Joana Peixoto, Jorge Pereira Lima · 2018 · Disease Models & Mechanisms
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis
Taparra, Kekoa, Wang, Hailun, Malek, Reem, Lafargue, Audrey, Barbhuiya, Mustafa A., Wang, Xing, Simons, Brian W., Ballew, Matthew, Nugent, Katriana, Groves, Jennifer et al. · 2018 · Journal of Clinical Investigation
PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells
Chen Liang, Si Shi, Mingyang Liu, Yi Qin, Qingcai Meng, Jie Hua, Shunrong Ji, Yu‐Qing Zhang, Jingxuan Yang, Jin Xu et al. · 2018 · Cancer Research
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
Yunguang Li, Shijie Tang, Xiaohan Shi, Jingwen Lv, Xueyuan Wu, Yehan Zhang, Huan Wang, Juan He, Yiqin Zhu, Yi Ju et al. · 2023 · Cell Reports Medicine
Plac8 Links Oncogenic Mutations to Regulation of Autophagy and Is Critical to Pancreatic Cancer Progression
Conan Grant Kinsey, Vijaya Balakrishnan, Michael R. O’Dell, Jing Li Huang, Laurel A. Newman, Christa L. Whitney‐Miller, Aram F. Hezel, Hartmut Land · 2014 · Cell Reports
Dysregulated glycolysis as an oncogenic event
Takumi Mikawa, Matilde Esther LLeonart, Akifumi Takaori‐Kondo, Nobuya Inagaki, Masayuki Yokode, Hiroshi Kondoh · 2015 · Cellular and Molecular Life Sciences
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
Christopher J. Tape, Stephanie Ling, Maria Dimitriadi, Kelly M. McMahon, Jonathan D. Worboys, Hui Sun Leong, Ida Christine Norrie, Crispin J. Miller, George Poulogiannis, Douglas A. Lauffenburger et al. · 2016 · Cell
ADAM17: An Emerging Therapeutic Target for Lung Cancer
Mohamed I. Saad, Stefan Rose‐John, Brendan John Jenkins · 2019 · Cancers
Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models
Garcia, Patrick L., Miller, Aubrey L., Yoon, Karina J. · 2020 · Cancers
Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer
Zhen Xing, Yanyan Zhang, Ke Liang, Yan Liang, Yu Xiang, Chunlai Li, Qingsong Hu, Feng Jin, Vasanta Putluri, Nagireddy Putluri et al. · 2018 · Cancer Research
Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
Toda, Kosuke, Nishikawa, Gen, Iwamoto, Masayoshi, Itatani, Yoshiro, Takahashi, Ryo, Sakai, Yoshiharu, Kawada, Kenji · 2017 · International Journal of Molecular Sciences
The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
Ruth Nussinov, Serena Muratcioğlu, Chung‐Jung Tsai, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Molecular Cancer Research
MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis
Wei Zhai, Junjie Ma, Rujian Zhu, Xu Chen, Jin Zhang, Yonghui Chen, Zhiguo Chen, Dongkui Gong, Jiayi Zheng, Chen Chen et al. · 2018 · British Journal of Cancer
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression
Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang · 2021 · Cancer and Metastasis Reviews
Pancreatic cancer cachexia: three dimensions of a complex syndrome
Maximilian Kordes, Lars Larsson, Lars Engstrand, Matthias J. Löhr · 2021 · British Journal of Cancer
The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Pedro González‐Menéndez, David Hevia, Juan C. Mayo, Rosa María Sainz · 2017 · International Journal of Cancer
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Kim, Seong M., Roy, Saurabh G., Chen, Bin, Nguyen, Tiffany M., McMonigle, Ryan J., McCracken, Alison N., Zhang, Yanling, Kofuji, Satoshi, Hou, Jue, Selwan, Elizabeth et al. · 2016 · Journal of Clinical Investigation
Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics
Santana-Codina, Naiara, Chandhoke, Amrita Singh, Yu, Qijia, Małachowska, Beata, Kuljanin, Miljan, Gikandi, Ajami, Stańczak, Marcin, Gableske, Sebastian, Jedrychowski, Mark P., Scott, David A. et al. · 2020 · Cell Reports
Pathological and Molecular Evaluation of Pancreatic Neoplasms
Arvind Rishi, Michael Goggins, Laura DeLong Wood, Ralph H. Hruban · 2014 · Seminars in Oncology
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Nicholas Alexander Graham, Aspram Minasyan, Anastasia Lomova, Ashley A. Cass, Nikolas G. Balanis, Michael Friedman, Shawna T. Chan, Sophie R. Zhao, Adrián Delgado, James L Go et al. · 2017 · Molecular Systems Biology
Mitochondrial Metabolism: Yin and Yang for Tumor Progression
Lorea Valcárcel-Jiménez, Edoardo Gaude, Verónica Torrano, Christian Frezza, Arkaitz Carracedo · 2017 · Trends in Endocrinology and Metabolism
Fatty acids – from energy substrates to key regulators of cell survival, proliferation and effector function
Danilo Cucchi, Dolores Camacho‐Muñoz, Michelangelo Certo, Valentina Pucino, Anna Nicolaou, Claudio Mauro · 2020 · Cell Stress
Exploiting pancreatic cancer metabolism: challenges and opportunities
Maria Chiara De Santis, Bruno Bockorny, Emilio Hirsch, Paola Cappello, Miriam Martini · 2024 · Trends in Molecular Medicine
Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
Masaaki Miyo, Masamitsu Konno, Naohiro Nishida, Toshinori Sueda, Kozo Noguchi, Hidetoshi Matsui, Hugh Shunsuke Colvin, Koichi Kawamoto, Jun Koseki, Naotsugu Haraguchi et al. · 2016 · Scientific Reports
UDP-sugar accumulation drives hyaluronan synthesis in breast cancer
Sanna Oikari, Tiia Kettunen, Satu Tiainen, Jukka Häyrinen, Amro Masarwah, Mazen Sudah, Anna Sutela, Ritva L. Vanninen, Markku Tammi, Päivi Auvinen · 2018 · Matrix Biology
Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy
Amoedo, N.D., Obre, E., Rossignol, R. · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Exploiting tumor metabolism: challenges for clinical translation
Matthew G. Vander Heiden · 2013 · Journal of Clinical Investigation
Elimination of oncogenic Kras in genetic mouse models eradicates pancreatic cancer by inducing Fas-dependent apoptosis by CD8+ T cells
K. Mahadevan, V. LeBleu, E. V. Ramirez, Yang Chen, Bing-Rui Li, Amari M. Sockwell, M. Gagea, H. Sugimoto, Lakshmi Kavitha Sthanam, D. Tampe et al. · 2023 · Developmental Cell
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, Laura Soucek · 2024 · Signal Transduction and Targeted Therapy
Metabolic reprogramming of metastatic breast cancer and melanoma bylet-7amicroRNA
Anastassia Serguienko, Iwona Grad, Anna Berit Wennerström, Leonardo A. Meza‐Zepeda, Bernd Thiede, Eva Wessel Stratford, Ola Myklebost, Else Munthe · 2014 · Oncotarget
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Tu, Bo, Yao, Jun, Ferri-Borgogno, Sammy, Zhao, Jun, Chen, Shujuan, Wang, Qiuyun, Yan, Liang, Zhou, Xin, Zhu, Cihui, Bang, Seungmin et al. · 2019 · JCI Insight
Squalene Synthase Induces Tumor Necrosis Factor Receptor 1 Enrichment in Lipid Rafts to Promote Lung Cancer Metastasis
Yi‐Fang Yang, Yi‐Hua Jan, Yu‐Peng Liu, Chih‐Jen Yang, Chia‐Yi Su, Yu‐Chan Chang, Tsung‐Ching Lai, Jean Chiou, Hong‐Yuan Tsai, Jean Lu et al. · 2014 · American Journal of Respiratory and Critical Care Medicine
FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC
Fengrui Zhou, Jianxiong Geng, Shanqi Xu, Qingwei Meng, Kexin Chen, Fang Liu, Fang Yang, Bo Pan, Yan Yu · 2019 · Aging
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Stefano Menini, Carla Iacobini, Martina Vitale, Carlo M. Pesce, Giuseppe Pugliese · 2021 · Cancers
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma
Virginia Giuliani, Meredith A. Miller, Chiu-Yi Liu, Stella R. Hartono, Caleb A. Class, Christopher Aaron Bristow, Érika Suzuki, Lionel A. Sanz, Guang Gao, Jason P. Gay et al. · 2021 · Nature Communications
Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression
Victoire Gouirand, Tristan Gicquel, Evan C. Lien, Emilie Jaune, Quentin Da Costa, Pascal Finetti, Elodie Metay, Camille Duluc, Jared R. Mayers, Stéphane Audebert et al. · 2022 · The EMBO Journal
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
Strand, Matthew S., Krasnick, Bradley A., Pan, Hua, Zhang, Xiuli, Bi, Ye, Brooks, Candace, Wetzel, Christopher, Sankpal, Narendra, Fleming, Timothy, Goedegebuure, S. Peter et al. · 2019 · Oncotarget
BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation
Zengxun Li, Yi Ge, Jie Dong, Hongwei Wang, Tiansuo Zhao, Xiuchao Wang, Jing Liu, Song Gao, Lei Shi, Shengyu Yang et al. · 2021 · Gastroenterology
Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ
Yi Liu, Yasunori Deguchi, Daoyan Wei, Fuyao Liu, Micheline J. Moussalli, Eriko Deguchi, Donghui Li, Huamin Wang, Lovie Ann Valentin, Jennifer K. Colby et al. · 2022 · Nature Communications
Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability
Hao-Lian Wang, Yan Chen, Yun-Qian Wang, Juan Tan, Juan Tan, Qianqian Liu, Chun-Min Li, Xuemei Tong, Qin‐Yan Gao, Jie Hong et al. · 2022 · Nature Communications
Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling
Ishan Roy, Donna M. McAllister, Egal Gorse, Kate J. Dixon, Clint Piper, Noah P. Zimmerman, Anthony E. Getschman, Susan Tsai, Dannielle D. Engle, Douglas B. Evans et al. · 2015 · Cancer Research
mTORC2 signaling drives the development and progression of pancreatic cancer
David R. Driscoll, S. Karim, M. Sano, D. Gay, Wright Jacob, Jun Yu, Yusuke Mizukami, A. Gopinathan, D. Jodrell, T. R. Jeffry Evans et al. · 2016 · Cancer Research
Mitochondrial determinants of cancer health disparities
Aaheli Roy Choudhury, Keshav Kumar Singh · 2017 · Seminars in Cancer Biology
Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA
Shan Huang, Zheng Wu, Yunyun Cheng, Wenzhen Wei, Linlin Hao · 2019 · Acta Biochimica et Biophysica Sinica
Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
Arturo Valle‐Mendiola, Isabel Soto‐Cruz · 2020 · Cancers
ERK2 Phosphorylates PFAS to Mediate Posttranslational Control of De Novo Purine Synthesis
Eunus Sheemul Ali, Umakant Sahu, Elodie Villa, Brendan P. O’Hara, Peng Gao, Cynthia Beaudet, Antony W. Wood, John M. Asara, Issam Ben‐Sahra · 2020 · Molecular Cell
A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
Vid Mlakar, Edouard Morel, Simona Jurković Mlakar, Marc Ansari, Fabienne Gumy‐Pause · 2021 · Journal of Experimental & Clinical Cancer Research
Tumor microenvironmental nutrients, cellular responses, and cancer
Graham P. Lobel, Yanqing Jiang, Marie Celeste Simon · 2023 · Cell chemical biology
Modulation of host central carbon metabolism and in situ glucose uptake by intracellular Trypanosoma cruzi amastigotes
Sheena Shah Tomko, Gaëlle Lentini, Peter C. Dumoulin, Barbara A. Burleigh · 2017 · PLoS Pathogens
Signaling Pathways Regulating Redox Balance in Cancer Metabolism
Maria Chiara De Santis, Paolo Ettore Porporato, Miriam Martini, Andrea Morandi · 2018 · Frontiers in Oncology
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Nicolas Jonckheere, Romain Vasseur, Isabelle VAN SEUNINGEN · 2017 · Critical Reviews in Oncology/Hematology
Obesity and Pancreatic Cancer: Insight into Mechanisms
Guido Eibl, Enrique Rozengurt · 2021 · Cancers
A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Li Ren Kong, Komal Gupta, Annan Wu, David Perera, Roland Iványi-Nagy, Syed Moiz Ahmed, Tuan Zea Tan, Shawn Lu-Wen Tan, Alessandra Fuddin, Elayanambi Sundaramoorthy et al. · 2024 · Cell
Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
Bo Kong, Chengjia Qia, Mert Erkan, Jorg H. Kleeff, Christoph W. Michalski · 2013 · Frontiers in Physiology
Covalent Guanosine Mimetic Inhibitors of G12C KRAS
Xiong, Yuan, Lu, Jia, Hunter, John, Li, Lianbo, Scott, David, Choi, Hwan Geun, Lim, Sang Min, Manandhar, Anuj, Gondi, Sudershan, Sim, Taebo et al. · 2017 · ACS Medicinal Chemistry Letters
Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
Emmanouil Fokas, Eric O’Neill, Alex Nicolas Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna, Ruth J. Muschel · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
Bongyong Lee, Iqbal Mahmud, John Marchica, Paweł Dereziński, Feng Qi, Fubo Wang, Piyush K. Joshi, Felipe Valerio, Inoel Rivera, Vipul Patel et al. · 2020 · Scientific Reports
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli et al. · 2021 · Frontiers in Oncology
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Tang Yuan, Ke Xu, Shilin Li, Ying Liu · 2024 · ACS Nano
Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, Shengpu Zhou, Shiqing Zhao, Mo Li, Baoshan Cao · 2025 · Molecular Cancer
Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
Masayoshi Iwamoto, Kenji Kawada, Yuji Nakamoto, Yoshiro Itatani, Susumu Inamoto, Kosuke Toda, Hiroyuki Kimura, Takehiko Sasazuki, Senji Shirasawa, Hiroaki Okuyama et al. · 2014 · Journal of Nuclear Medicine
Attacking the supply wagons to starve cancer cells to death
Elizabeth M. Selwan, Brendan T. Finicle, Seong Min Kim, Aimee L. Edinger · 2016 · FEBS Letters
Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
Huai‐Qiang Ju, Zhuo-Nan Zhuang, Hao Li, Tian Tian, Yun‐Xin Lu, Xiao-Qiang Fan, Haijun Steve Zhou, Hai‐Yu Mo, Hui Sheng, Paul J. Chiao et al. · 2016 · Cancer Letters
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease
Javier de las Heras, Luis Jose Aldamiz-Echevarria, Maria Luz Martínez‐Chantar, Teresa C. Delgado · 2016 · Expert Opinion on Drug Metabolism & Toxicology
A Novel Quantitative Mass Spectrometry Platform for Determining Protein O-GlcNAcylation Dynamics
Xiaoshi Wang, Zuo‐Fei Yuan, Jing Fan, Kelly R. Karch, Lauren Elizabeth Ball, John M. Denu, Benjamin A. Garcia · 2016 · Molecular & Cellular Proteomics
Exosomal Circ-MEMO1 Promotes the Progression and Aerobic Glycolysis of Non-small Cell Lung Cancer Through Targeting MiR-101-3p/KRAS Axis
Chengzhi Ding, Gaoyuan Xi, Guolei Wang, Dong Cui, Binbin Zhang, Hongtao Wang, Gongqian Jiang, Jingchao Song, Guanghui Xu, Jiao Wang · 2020 · Frontiers in Genetics
Macrophages in pancreatic cancer: An immunometabolic perspective
Jian Min Yang, Yongzheng Li, Zhaowei Sun, Hanxiang Zhan · 2020 · Cancer Letters
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Tomas Koltai, Khalid Omer Alfarouk, Stephan J. Reshkin, Rosa Angela Cardone · 2021 · Cancers
Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma
Peng Tian, Fang Sun, Jia-Chun Yang, Mei-Hong Cai, Manxiu Huai, Jiaxing Pan, Feiyu Zhang, Leiming Xu · 2024 · World Journal of Gastroenterology
Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal‐Basterra, Arkaitz Carracedo · 2024 · British Journal of Cancer
Targeted metabolomics in cultured cells and tissues by mass spectrometry: Method development and validation
Anas M. Abdel Rahman, Judy Pawling, Michael C. Ryczko, Amy A. Caudy, James W. Dennis · 2014 · Analytica Chimica Acta
Probing the Hexosamine Biosynthetic Pathway in Human Tumor Cells by Multitargeted Tandem Mass Spectrometry
Anas M. Abdel Rahman, Michael C. Ryczko, Judy Pawling, James W. Dennis · 2013 · ACS Chemical Biology
Functional implication of Dclk1 and Dclk1-expressing cells in cancer
Christoph Benedikt Westphalen, Michael Quante, Timothy Cragin Wang · 2016 · Small GTPases
The Tumor Microenvironment in Colorectal Cancer Therapy
Leire Pedrosa, Francis María Esposito, Timothy M. Thomson, Joan Maurel · 2019 · Cancers
Metabolic Alterations in Pancreatic Cancer Progression
Enza Vernucci, Jaime Abrego, Venugopal Gunda, Surendra Kumar Shukla, Aneesha Dasgupta, Vikrant Rai, Nina V. Chaika, Kyla B. Buettner, Alysha L. Illies, Fang Yu et al. · 2019 · Cancers
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Rajbhandari, Nirakar, Lin, Wan-chi, Wehde, Barbara L., Triplett, Aleata A., Wagner, Kay-Uwe · 2017 · Cell Reports
Genetics and Genetic Testing in Pancreatic Cancer
David Clement Whitcomb, Celeste A. Shelton, Randall E. Brand · 2015 · Gastroenterology
Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis
Wentao Dong, Mark A. Keibler, Gregory N Stephanopoulos · 2017 · Metabolic Engineering
Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer
Mahua Roy, Stacey D. Finley · 2017 · Frontiers in Physiology
c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3
Huanhuan Ma, Jia Zhang, Lin Zhou, Shixiong Wen, Hsiang-Yu Tang, Bin Jiang, Fengqiong Zhang, Muhammad Suleman, Dachao Sun, Ai Chen et al. · 2020 · Cell Reports
Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
Chien‐shan Cheng, Hor‐Yue Tan, Ning Wang, Lianyu Chen, Zhiqiang Meng, Zhen Chen, Yibin Feng · 2021 · Clinical and Translational Medicine
Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance
Koelina Ganguly, Rakesh Bhatia, Sanchita Rauth, Andrew Kisling, Pranita Atri, Christopher M. Thompson, Raghupathy Vengoji, Shiv Ram Krishn, Dhananjay D. Shinde, Vinai Chittezham Thomas et al. · 2021 · Gastroenterology
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas
David J. Falvo, Adrien Grimont, Paul Zumbo, William B. Fall, Julie L. Yang, Alexa Osterhoudt, Grace Pan, André F. Rendeiro, Yinuo Meng, John Erby Wilkinson et al. · 2023 · Developmental Cell
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Richard Francis Dunne, Aram F. Hezel · 2015 · Hematology/Oncology Clinics of North America
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
Chuanzong Zhao, Ben Wang, Enyu Liu, Zongli Zhang · 2020 · Cell Communication and Signaling
The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
Eran Fridman, Lana Ginini, Ziv Gil · 2022 · Cells
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Caleb Cheng, Jing Hu, R. Mannan, Tongchen He, Rupam Bhattacharyya, Brian Magnuson, Jasmine P. Wisniewski, Sydney Peters, S. Karim, David J. MacLean et al. · 2025 · Nature
Functional Characterization of the Plastidial 3-Phosphoglycerate Dehydrogenase Family in Arabidopsis
Walid Toujani, Jesús Muñoz‐Bertomeu, María Flores‐Tornero, Sara Rosa‐Téllez, Armand Djoro Anoman, Saleh Alseekh, Alisdair Robert Fernie, Roc Ros · 2013 · PLANT PHYSIOLOGY
EMT-induced metabolite signature identifies poor clinical outcome
Salil Kumar Bhowmik, Esmeralda Ramirez‐Peña, James M. Arnold, Vasanta Putluri, Nathalie Sphyris, George C. Michailidis, Nagireddy Putluri, Stefan Ambs, Arun Sreekumar, Sendurai A. Mani · 2015 · Oncotarget
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
Hengqiang Zhao, Shihong Wu, Hehe Li, Qingke Duan, Zhengle Zhang, Qiang Shen, Chunyou Wang, Tao Yin · 2019 · Molecular Therapy — Oncolytics
Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor‐κ B activation
Huai‐Qiang Ju, Hao Li, Tian Tian, Yun‐Xin Lu, Long Bai, Le-Zong Chen, Hui Sheng, Hai‐Yu Mo, Jun‐Bo Zeng, Wuguo Deng et al. · 2015 · Journal of Pineal Research
Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype
Jiujie Cui, Ming Quan, Weihua Jiang, Hai Xia Hu, Feng Jiao, Ning Li, Ziliang Jin, Lei Wang, Yu Wang, Liwei Wang · 2015 · Medical Oncology
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer
Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu et al. · 2016 · Cancer Letters
Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids
Junchen Liu, Ransome van der Hoeven, Walaa E. Kattan, Jeffrey T. Chang, Dina Montufar‐Solis, Wei Chen, Maurice Wong, Yong Zhou, Carlito B. Lebrilla, John F. Hancock · 2023 · Nature Communications